Urticaria Clinical Trials

82 clinical trials for Urticaria across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients — RECRUITING · NA
• A 52-WEEK MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, BASKET STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF REMIBRUTINIB (LOU064) IN CHRONIC INDUCIBLE URTICARIA (CINDU) IN ADULTS INADEQUATELY CONTROLLED BY H1-ANTIHISTAMINES — RECRUITING
• Skin diseases and the association with addictive diseases — RECRUITING
• A Single-Arm Exploratory Study of NatureU Histra Dissolve on Chronic Urticaria Symptoms — COMPLETED · NA
• A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology — NOT_YET_RECRUITING · NA
• Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief — NOT_YET_RECRUITING · NA
• Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares — COMPLETED · PHASE2
• Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria — COMPLETED · PHASE2
• Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care — COMPLETED
• Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions. — COMPLETED
• COrticosteroids in acUte uRticAria in emerGency dEpartment — COMPLETED · PHASE3
• To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions — COMPLETED · PHASE1
• A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria — NOT_YET_RECRUITING · NA
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE-RANGING STUDY EVALUATING THE EFFICACY AND SAFETY OF EVO756 IN ADULTS WITH MODERATE TO SEVERE CHRONIC SPONTANEOUS URTICARIA — COMPLETED
• Survey on the Characteristics of Traditional Medicine Syndromes in Urticaria Patients At Le Van Thinh Hospital — NOT_YET_RECRUITING
• GI Symptoms in Infants Fed Goat Milk-based Infant Formula — COMPLETED
• A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736) — TERMINATED · PHASE4
• A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735) — COMPLETED · PHASE4
• A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) — COMPLETED · PHASE4
• An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201) — COMPLETED · PHASE3
• Angioedema Biomarker Research Study — OTHER
• The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment — COMPLETED · NA
• Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China. — OTHER
• The Association Between Human Microbiome and Vitamin D in Chronic Urticaria — OTHER · NA
• Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema — COMPLETED
• Role of Circulating Innate Lymphoid Cells in Allergic Disorders — TERMINATED
• PHASE 1B, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF EP262 IN SUBJECTS WITH CHRONIC INDUCIBLE URTICARIA — COMPLETED · PHASE1
• Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% — COMPLETED · PHASE1
• A Long-Term Examination of Asthma From Childhood Through Adolescence — COMPLETED
• A MULTI-CENTER, SINGLE-ARM STUDY TO INVESTIGATE THE PHARMACOKINETICS AND SAFETY OF DUPILUMAB IN MALE AND FEMALE PARTICIPANTS ¿2 YEARS TO <12 YEARS OF AGE WITH UNCONTROLLED CHRONIC SPONTANEOUS URTICARIA (CSU) OR CHRONIC INDUCIBLE COLD URTICARIA (CICU) — COMPLETED
• Using Doxepin for Urticaria — OTHER · PHASE3
• Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria — TERMINATED · PHASE2
• How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988) — COMPLETED · PHASE3
• An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540) — COMPLETED · PHASE4
• Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) — COMPLETED
• Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED) — COMPLETED
• Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria — COMPLETED
• Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children — OTHER · PHASE4
• Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers — COMPLETED
• A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU). — COMPLETED · PHASE2
• A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study — TERMINATED · PHASE2
• Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department. — COMPLETED · NA
• Evaluating for Contact Allergies in Patients With Chronic Urticaria — COMPLETED
• A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria — OTHER · PHASE4
• Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264 — COMPLETED · PHASE1
• Mental itch induction in patients with atopic dermatitis, urticaria and psoriasis vs. healthy controls — OTHER
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED PHASE 2B DOSE FINDING STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF LOU064 IN ADULT CHRONIC SPONTANEOUS URTICARIA PATIENTS INADEQUATELY CONTROLLED BY H1-ANTIHISTAMINES — COMPLETED · PHASE2
• Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria — COMPLETED · PHASE1
• Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation — WITHDRAWN · PHASE4
• Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients — TERMINATED · NA

Refine this search